Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.69% | -1,014.59% | -274.96% | -185.49% | -154.05% |
| Total Depreciation and Amortization | 16.57% | 20.70% | 27.51% | 29.87% | 28.02% |
| Total Amortization of Deferred Charges | -1.13% | 4.96% | 4.92% | 5.06% | 5.06% |
| Total Other Non-Cash Items | 9.89% | 203.06% | -21.60% | -60.99% | -70.09% |
| Change in Net Operating Assets | -112.89% | -100.28% | -95.83% | -40.11% | 317.04% |
| Cash from Operations | -94.09% | -86.27% | -90.14% | -92.88% | -76.45% |
| Capital Expenditure | 54.76% | 26.12% | -4.90% | -185.23% | -283.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | 100.16% | 70.87% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.48% | 359.68% | 356.19% | 249.09% | 205.68% |
| Cash from Investing | 80.12% | 74.76% | 67.15% | 40.66% | 54.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,971.83% | -7.19% | -8.95% | -8.77% | 58.46% |
| Issuance of Common Stock | -- | -- | -78.44% | -59.31% | -71.84% |
| Repurchase of Common Stock | -204.39% | -449.85% | -444.14% | -435.74% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.80% | 107.18% | 105.21% | 78.15% | 70.01% |
| Cash from Financing | -285.84% | 100.74% | 100.56% | 74.46% | 67.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -341.73% | 96.17% | -123.75% | -133.83% | -170.70% |